4//SEC Filing
Bellon Steven F. 4
Accession 0001562180-24-006767
CIK 0001822462other
Filed
Sep 10, 8:00 PM ET
Accepted
Sep 11, 4:00 PM ET
Size
5.0 KB
Accession
0001562180-24-006767
Insider Transaction Report
Form 4
Bellon Steven F.
Chief Scientific Officer
Transactions
- Sale
Common Stock
2024-09-09$9.50/sh−20,000$190,000→ 101,957 total
Footnotes (1)
- [F1]The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 11, 2024.
Documents
Issuer
Foghorn Therapeutics Inc.
CIK 0001822462
Entity typeother
Related Parties
1- filerCIK 0001831749
Filing Metadata
- Form type
- 4
- Filed
- Sep 10, 8:00 PM ET
- Accepted
- Sep 11, 4:00 PM ET
- Size
- 5.0 KB